SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vinicius de Lima Vazquez, Anna L. Vicente, Adriana Carloni, Gustavo Berardinelli, Paula Soares, Cristovam Scapulatempo, Olga Martinho, Rui M. Reis, Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas, Melanoma Research, 2016, 26, 2, 93

    CrossRef

  2. 2
    Alexander Kadokura, Noah Frydenlund, Dominick A. Leone, Shi Yang, Mai P. Hoang, April Deng, Marier Hernandez-Perez, Asok Biswas, Rajendra Singh, Ron Yaar, Meera Mahalingam, Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver?, Human Pathology, 2016, 53, 82

    CrossRef

  3. 3
    A Hunter Shain, Maria Garrido, Thomas Botton, Eric Talevich, Iwei Yeh, J Zachary Sanborn, Jongsuk Chung, Nicholas J Wang, Hojabr Kakavand, Graham J Mann, John F Thompson, Thomas Wiesner, Ritu Roy, Adam B Olshen, Alexander Gagnon, Joe W Gray, Nam Huh, Joe S Hur, Klaus J Busam, Richard A Scolyer, Raymond J Cho, Rajmohan Murali, Boris C Bastian, Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway, Nature Genetics, 2015, 47, 10, 1194

    CrossRef

  4. 4
    V. A. Heinstein, A. G. Ievleva, E. N. Imyanitov, K. V. Shelekhova, Immunohistochemical and genetic profiles of melanomas with spindle cell morphology, Arkhiv patologii, 2015, 77, 4, 17

    CrossRef

  5. 5
    Stephan W Jahn, Karl Kashofer, Iris Halbwedl, Gerlinde Winter, Laila El-Shabrawi-Caelen, Thomas Mentzel, Gerald Hoefler, Bernadette Liegl-Atzwanger, Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis, Modern Pathology, 2015, 28, 7, 895

    CrossRef

  6. 6
    Nicole A Cipriani, Igor Letovanec, Francis J Hornicek, John T Mullen, Zhenfeng Duan, Darrell R Borger, Gunnlaugur Petur Nielsen, BRAF mutation in ‘sarcomas’: a possible method to detect de-differentiated melanomas, Histopathology, 2014, 64, 5
  7. 7
    S. Lorcy, M.-C. Koeppel, M.-A. Richard, J.-J. Grob, P. Berbis, J.-J. Morand, Mélanome desmoplastique : une série de 23 cas dans trois centres des Bouches-du-Rhône, Annales de Dermatologie et de Vénéréologie, 2014, 141, 11, 656

    CrossRef

  8. 8
    Stefan Kraft, Scott R. Granter, Molecular Pathology of Skin Neoplasms of the Head and Neck, Archives of Pathology & Laboratory Medicine, 2014, 138, 6, 759

    CrossRef

  9. 9
    Boris C. Bastian, The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia, Annual Review of Pathology: Mechanisms of Disease, 2014, 9, 1, 239

    CrossRef

  10. 10
    F. Sclafani, G. Gullo, K. Sheahan, J. Crown, BRAF mutations in melanoma and colorectal cancer: A single oncogenic mutation with different tumour phenotypes and clinical implications, Critical Reviews in Oncology/Hematology, 2013, 87, 1, 55

    CrossRef

  11. 11
    Lucy L. Chen, Natalia Jaimes, Christopher A. Barker, Klaus J. Busam, Ashfaq A. Marghoob, Desmoplastic melanoma: A review, Journal of the American Academy of Dermatology, 2013, 68, 5, 825

    CrossRef

  12. 12
    Dale Han, Jonathan S. Zager, Daohai Yu, Xiuhua Zhao, Brooke Walls, Suroosh S. Marzban, Nikhil G. Rao, Vernon K. Sondak, Jane L. Messina, Desmoplastic Melanoma: Is There a Role for Sentinel Lymph Node Biopsy?, Annals of Surgical Oncology, 2013, 20, 7, 2345

    CrossRef

  13. 13
    Benjamin A. Wood, Desmoplastic melanoma: Recent advances and persisting challenges, Pathology, 2013, 45, 5, 453

    CrossRef

  14. 14
    Jinhyun Kim, Alexander J. Lazar, Michael A. Davies, Jade Homsi, Nicholas E. Papadopoulos, Wen-jen Hwu, Agop Y. Bedikian, Scott E. Woodman, Sapna P. Patel, Patrick Hwu, Kevin B. Kim, BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma, Journal of Cutaneous Pathology, 2012, 39, 9
  15. 15
    S. Coupelon, F. Franck, A.S. Jarrousse, P. Déchelotte, P. Souteyrand, M. D’Incan, Desmoplastic Malignant Melanoma: A Study of Ten Cases and Status of BRAF Mutation, Dermatology, 2012, 225, 2, 168

    CrossRef

  16. 16
    Fritz Lai, Chen Chen Jiang, Margaret L. Farrelly, Xu Dong Zhang, Peter Hersey, Evidence for upregulation of Bim and the splicing factor SRp55 in melanoma cells from patients treated with selective BRAF inhibitors, Melanoma Research, 2012, 22, 3, 244

    CrossRef

  17. 17
    Daniel D Miller, Andrew Emley, Shi Yang, Joanna E Richards, Jung Eun Lee, April Deng, Mai P Hoang, Meera Mahalingam, Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal, Modern Pathology, 2012, 25, 4, 505

    CrossRef

  18. 18
    J.-H. Lee, J.-W. Choi, Y.-S. Kim, Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis, British Journal of Dermatology, 2011, 164, 4
  19. 19
    Zhuang Feng, Xiaocheng Wu, Vivien Chen, Ellen Velie, Zhenzhen Zhang, Incidence and survival of desmoplastic melanoma in the United States, 1992–2007, Journal of Cutaneous Pathology, 2011, 38, 8
  20. 20
    David C. Whiteman, William J. Pavan, Boris C. Bastian, The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin, Pigment Cell & Melanoma Research, 2011, 24, 5
  21. 21
    David Weedon, Weedon's Skin Pathology, 2010,

    CrossRef

  22. 22
    N Narita, A Tanemura, R Murali, R A Scolyer, S Huang, T Arigami, S Yanagita, K K Chong, J F Thompson, D L Morton, D S Hoon, Functional RET G691S polymorphism in cutaneous malignant melanoma, Oncogene, 2009, 28, 34, 3058

    CrossRef

  23. 23
    Amena M. DeLuca, Archana Srinivas, Rhoda M. Alani, BRAF kinase in melanoma development and progression, Expert Reviews in Molecular Medicine, 2008, 10,

    CrossRef

  24. 24
    P.D. Da Forno, A. Fletcher, J.H. Pringle, G.S. Saldanha, Understanding spitzoid tumours: new insights from molecular pathology, British Journal of Dermatology, 2008, 158, 1
  25. 25
    Marie-France Demierre, Melanoma: Translational Research and Emerging Therapies, 2008,

    CrossRef

  26. 26
    Carmelo Urso, Melanocytic Lesions, Spitz Tumors, and Don Ferranteʼs Logic, The American Journal of Dermatopathology, 2007, 29, 5, 491

    CrossRef

  27. 27
    David A. Lee, Jason A. Cohen, William S. Twaddell, Gustavo Palacios, Melissa Gill, Eyal Levit, Alan J. Halperin, Joan Mones, Klaus J. Busam, David N. Silvers, Julide Tok Celebi, Are all melanomas the same?, Cancer, 2006, 106, 4
  28. 28
    Timothy M. Pawlik, Merrick I. Ross, Victor G. Prieto, Matthew T. Ballo, Marcella M. Johnson, Paul F. Mansfield, Jeffrey E. Lee, Janice N. Cormier, Jeffrey E. Gershenwald, Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma, Cancer, 2006, 106, 4
  29. 29
    Nancy E. Thomas, BRAF somatic mutations in malignant melanoma and melanocytic naevi, Melanoma Research, 2006, 16, 2, 97

    CrossRef

  30. 30
    S Forbes, J Clements, E Dawson, S Bamford, T Webb, A Dogan, A Flanagan, J Teague, R Wooster, P A Futreal, M R Stratton, COSMIC 2005, British Journal of Cancer, 2006, 94, 2, 318

    CrossRef

  31. 31
    Vikas K. Goel, Alexander J.F. Lazar, Carla L. Warneke, Mark S. Redston, Frank G. Haluska, Examination of Mutations in BRAF, NRAS, and PTEN in Primary Cutaneous Melanoma, Journal of Investigative Dermatology, 2006, 126, 1, 154

    CrossRef

  32. 32
    Marie-France Demierre, What about chemoprevention for melanoma?, Current Opinion in Oncology, 2006, 18, 2, 180

    CrossRef

  33. 33
    Steven Kazianis, Meenhard Herlyn, Skin Cancer Prevention, 2006,

    CrossRef

  34. 34
    Melissa Gill, Julide Tok Celebi, B-RAF and melanocytic neoplasia, Journal of the American Academy of Dermatology, 2005, 53, 1, 108

    CrossRef